Extra Space Storage pricing power is back for the first time in three years, according to the company’s 2025 Annual Report, lifting EXR as the operationally improved name in a trio of stocks linked to the “Bank of Mom and Dad” spending trend alongside UnitedHealth Group (UNH) and DoorDash (DASH).
| Ticker | Consensus Rating | Price Target | Current Price | Dividend Yield |
|---|---|---|---|---|
| EXR | Hold | $152.29 | $148.20 | 4.37% |
| UNH | Moderate Buy | $407.17 | $412.57 | 2.14% |
| DASH | Moderate Buy | $259.58 | $155.67 | N/A |
Extra Space Storage Pricing Power and the Self-Storage Setup
The self-storage sector spent several years absorbing a wave of new supply. For EXR, that cycle is turning. The company reported positive FFO-per-share growth in 2025 alongside positive same-store revenue growth, despite persistent headwinds from that supply overhang. The key development: new supply is moderating, and EXR regained Extra Space Storage pricing power with new customers for the first time in three years.
Analysts rate EXR a Hold with a $152.29 consensus price target, roughly 3% above the current $148.20 price. That spread is tight enough to explain the Hold rather than a Buy, but it is not a rejection of the Extra Space Storage pricing power thesis. The 4.37% dividend yield gives income-oriented holders a reason to stay patient.
The intergenerational spending angle for EXR is direct. When parents fund adult children through housing transitions, storage demand follows. That demographic tailwind, combined with the Extra Space Storage pricing power recovery, is the core bull case. The debate is whether the recovery is durable or whether any residual supply keeps a lid on rate growth.
UNH and DASH: Ratings, Risk Factors, and What Comes Next
UnitedHealth Group carries a Moderate Buy consensus with a $407.17 price target, which sits below the current price of $412.57. That inversion reflects real uncertainty. The Q1 2026 earnings release disclosed active DOJ legal actions tied to the company’s Medicare program participation, plus risks from the pending sale of its remaining South American operations.
Both items are live overhangs. The UnitedHealth Group newsroom confirmed Q2 2026 earnings have been scheduled, giving investors a near-term event to watch. How management addresses the DOJ situation on that call will likely matter more than the headline numbers for short-term positioning.
DoorDash is the highest-conviction name by consensus. The $259.58 price target sits roughly 67% above the current $155.67, a gap that reflects growth expectations rather than near-term fundamentals. DoorDash’s 10-K for fiscal year 2025, filed with the SEC in February 2026, addressed cybersecurity risks and management’s discussion of financial condition. Those disclosures are the baseline for assessing whether the margin trajectory can support that $259 target.
The intergenerational angle for DASH: parents subsidizing household budgets for adult children sustains delivery order volumes. That is the demand driver embedded in the Moderate Buy thesis.
Three different catalysts set the timeline here. DoorDash needs margin clarity to close the gap to its target. UNH’s setup is binary on the DOJ outcome. For EXR, watch whether the Extra Space Storage pricing power gain holds through the second half of 2026 as remaining supply clears and whether that 3% upside to target widens enough to shift the consensus off Hold.
